Michael Czech to receive CIIT Founders' Award

April 24, 2000

Dr. Michael P. Czech, Professor of Biochemistry and Molecular Biology at the University of Massachusetts Medical School, will be the 31st recipient of the CIIT Founders' Award, presented annually to recognize career contributions to human health research and risk assessment.

Professor Czech is being honored for his pioneering work on the molecular action of insulin on glucose transport and its impact on the study of diabetes. He is also recognized for adding to the fundamental knowledge of the cell signaling process, which improves our understanding of potential actions of environmental endocrine-active compounds.

The Founders' Award will be presented at the public session of CIIT's Annual Meeting, May 9, at the Embassy Suites Hotel, 201 Harrison Oaks Blvd., Cary, NC. Following the presentation Dr. Czech will speak on "Fat as an Endocrine Organ: Target for Environmental Toxins."

Dr. Czech received a B.A. degree in chemistry from Brown University in 1967, an M.A. in biochemistry from Duke University in 1969, and a Ph.D. in biochemistry from Brown University in 1972. He was a U.S. Public Health Service postdoctoral fellow at Duke from 1972 to 1974. He was a faculty member in Medical Science at Brown University from 1974 to 1981. He joined the Department of Biochemistry and Molecular Biology at the University of Massachusetts Medical School in 1981 as Professor and Chair and became Director of the Program in Molecular Medicine in 1989. He is also affiliated with the Center for AIDS Research. Over 40 fellows and other postdoctoral personnel have trained in his laboratory.

He is the co-author of over 200 scientific publications and has been a member of numerous scientific advisory boards and review panels. He has served on the editorial boards of 18 scientific journals. His work has been recognized with many awards, most recently the 2000 Banting Medal for Scientific Achievement by the American Diabetes Association.
-end-
CIIT is a scientifically independent, not-for-profit institute, focusing on environmental and human health research. It is supported by 34 member companies and the Chemical Manufacturers Association. CIIT is dedicated to world-class research that can be used to develop regulations and voluntary programs to help ensure the safe use of chemicals. Its research is published in peer-reviewed scientific journals.

CIIT - Chemical Industry Institute of Toxicology

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.